In this Mission Matters episode, ⁠Adam Torres⁠ interviews ⁠Doug Drysdale⁠, CEO of Cybin, about the groundbreaking work his company is doing to develop psychedelic-based treatments for mental health conditions. From clinical trials to regulatory challenges, Doug shares his mission to transform suffering into healing through next-generation therapeutics.

Follow Adam on Instagram at ⁠https://www.instagram.com/askadamtorres/⁠ for up to date information on book releases and tour schedule.

Apply to be a guest on our podcast:

⁠https://missionmatters.lpages.co/podcastguest/⁠

Visit our website:

⁠https://missionmatters.com/⁠

More FREE content from Mission Matters here: ⁠https://linktr.ee/missionmattersmedia⁠

Learn more about your ad choices. Visit podcastchoices.com/adchoices